From January 1, 2024 to March 31, 2024, the company has repurchased 230,200 shares, representing 0.02% for CNY 7 million. With this, the company has completed the repurchase of 961,700 shares, representing 0.1% for CNY 27.09 million under the buyback announced on July 4, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.06 CNY | -1.37% | -0.19% | +30.64% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.64% | 531.1Cr | |
+29.98% | 68TCr | |
+30.34% | 57TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+16.21% | 24TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+7.09% | 17TCr |
- Stock Market
- Equities
- 600566 Stock
- News Hubei Jumpcan Pharmaceutical Co., Ltd.
- Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.